Substituted N-(3,5-dichlorobenzenesulfonyl)-L-prolyl-phenylalanine analogues as potent VLA-4 antagonists.
暂无分享,去创建一个
M. Maccoss | W. Hagmann | K. Lyons | L. Lin | John A. Schmidt | D. Levorse | S. Mills | R. Mumford | Ermengilda D McCauley | P. A. Magriotis | R. Stearns | Junying Wang | S. Vincent | A. Colletti | S. Tong | G. van Riper | U. Kidambi | I. E. Kopka | D. Young | K. Owens | Zhen Wang | Song Zheng | Linda E Egger
[1] Jacqueline Palace,et al. The effect of anti-α4 integrin antibody on brain lesion activity in MS , 1999, Neurology.
[2] D Seiffge,et al. Protective effects of monoclonal antibody to VLA-4 on leukocyte adhesion and course of disease in adjuvant arthritis in rats. , 1996, The Journal of rheumatology.
[3] M. Humphries,et al. The minimal essential sequence for a major cell type-specific adhesion site (CS1) within the alternatively spliced type III connecting segment domain of fibronectin is leucine-aspartic acid-valine. , 1991, The Journal of biological chemistry.
[4] M. Elices,et al. Structure of the Integrin VLA‐4 and its Cell‐Cell and Cell‐Matrix Adhesion Functions , 1990, Immunological reviews.